Radiotherapy Protocols Bristol protocol version 12.

Slides:

Advertisements

Similar presentations

Mammary ductal carcinoma

Advertisements

BREAST CANCER CASE STUDY FRAZER BELL STUDENT BMS BSc APPLIED BIOMEDICAL SCIENCE.

Pimp Session: Breast By James Lee, MD.

Breast Cancer, A Common Problem in Sri Lanka

Tumor Size and Sentinel Node Procedure A. Ph. MAKAR, MD, Ph.D. R. Van Den Broecke, MD, Ph.D. Depart of Senology & Gynaecologic Oncology The Middelheim.

Breast Cancer. Introduction Most common female cancer Accounts for 32% of all female cancer 211,300 new cases yearly and rising 40,000 deaths yearly.

Contraindications to sentinel lymph node biopsy Martine Berliere GGOLFB Breast Clinic Cancer Center Cliniques Universitaires St Luc.

Increased Postoperative Complications in Bilateral Mastectomy Patients Compared to Unilateral Mastectomy: An Analysis of NSQIP Database Osman F, Saleh.

Undifferenciated sarcoma MH. Female 67 years old Weight loss 15 kg Self palpation a mass of proximal thight MH.

DCIS – Are we cutting it? Dr Alex Lemaigre With thanks to:

Role of Nodal Irradiation in Breast Cancer

Connie Lee, M.D. UF Surgery

Malignant Adenomyoepithelioma of the Breast with Lymph Node Metastasis

Breast Cancer Who Gets What Type of Surgery? Murray Pfeifer 16 th August, 2014.

Breast diseases Csaba Kósa M.D..

AJCC TNM Staging 7th Edition Breast Case #3

Local Management of Invasive Breast Cancer

 Most commonly diagnosed cancer among women in Australia.  Lifetime risk of 1 in 9, risk increases with age.

Radiotherapy in Carcinoma of the Breast Patrick S Swift, MD Director, Radiation Oncology Alta Bates Comprehensive Cancer Center Berkeley, CA.

Breast Conservation Surgery

Hot topics in breast radiotherapy Mark Beresford.

West Midlands Cancer Intelligence Unit NHSBSP Surgical QA Data for the Year of Screening 1 April 2002 to 31 March 2003 Dr Gill Lawrence and Professor Jan.

AJCC Staging Moments AJCC TNM Staging 7th Edition Breast Case #2 Contributors: Stephen B. Edge, MD Roswell Park Cancer Institute, Buffalo, New York David.

Elshami M.Elamin, MD Medical Oncologist Central Care Cancer Center Wichita, KS, USA

AJCC Staging Moments AJCC TNM Staging 7th Edition Breast Case #1 Contributors: Stephen B. Edge, MD Roswell Park Cancer Institute, Buffalo, New York David.

SYB Case 2 By: Amy. History 63 y/o female History of left breast infiltrating duct carcinoma s/p mastectomy in 1996 and chemotherapy ER negative, PR negative,

Breast Carcinoma. Anatomy Epidemiology: 10% 17.1/10 28/10 46/ m world wide 6% develop cancer of the breast in their lifetime. 50,000 to 70,000.

Putting the Puzzle Together: Breast Collaborative Staging Melissa Riddle, RHIT, CTR October 6, 2012.

 General recommendations -adjuvant systemic therapy :with tamoxifen or multiple-chemotherapy agent :lower the incidence of recurrence by about 30% - in.

Management of DCIS KWH Experience Dr. Carmen Ho.

The Treatment of the Axilla in the North of England Cancer Network. Henry Cain ST7 North Tyneside.

Evidence Based For invasive breast cancer BCT is Tumor excision, axillary node dissection, whole breast radiation Modified mastectomy is total mastectomy.

AJCC 6 TH EDITION STAGING OF BREAST CARCINOMA. AJCC NODE STAGING -16 CATEGORIES pNX – 1 option pN0 – 5 options; null,(i-),(i+),(mol-),(mol+) pN1 – 4.

Katie Ludwig FY1.   50, 285 New cases of breast cancer  11, 716 deaths  78% - 10 year survival rates  27% preventable cases  Source:

TREATMENT Mastectomy -traditionally, treatment of breast ca has been surgical -19 century, surgical treatment : local excision ~ total mastectomy : radical.

1789 patients, 1982 – 1989, premenopausal, node + or Tumor > 5cm, M0 Total mastectomy, level I + II (partly) + CMF +/- 50Gy/25fx (electrons + photons)

Radical Mastectomy is no longer the standard Improved adjuvant and neoadjuvant therapy Chemotherapy Endocrine therapy Radiation treatment Reconstruction.

Lisa Mifsud. Assessment and Management of Surgical Breast Disease.

Ductal Carcinoma in Situ with Microinvasion: Prognostic Implications, Long-term Outcomes, and Role of Axillary Evaluation Rahul R. Parikh, MD 1, Bruce.

Quality Assurance Report TTUHSC Breast Center of Excellence January 1, 2014 – December 31, 2014 Compiled by L.Day, RN BSN CCM CCRP OCN 1.

The breast disease. Benign disease Present as; 1. Pain 2. Mass 3. Discharge 4. Abnormal appearance.

Case scenario- Breast Lump

SLNB The RUH experience A 2014 Audit Dr M Stoddart, Dr S Cole, Mr J Horsnell and Mr R Sutton Royal United Hospital, Bath.

SLNB Scenario Group Discussion Presented at: The Sentinel Lymph Node Biopsy Surgery Refresher Course October 29, 2010.

Breast Cancer 1. Leukemia & Lymphoma New diagnoses each year in the US: 112, 610 Adults 5,720 Children 43,340 died of leukemia or lymphoma in

Annals of Oncology 24: 2206–2223, 2013 R3 조영학

Figure 1: a 32-year-old woman presented with RT breast mass, MRI showed false positive diagnosis of cancer. Dynamic contrast enhanced MRI, axial subtraction.

Case Discussion. Case #1 64 year-old postmenopausal, no PMHx Routine MMG: 2cm nodule in RUQ, with microcalcifications Biopsy: IDC grade 2 with areas of.

The New trends in the Management of Breast Cancer 謝渙發桃園縣醫師公會監事怡仁綜合醫院副院長教育部部定助理教授國防醫學院外科學系臨床教授.

Breast Care Leicester Breast Problems - Together we can make a difference Simon Pilgrim MA MBBS MD FRCS Monika Kaushik MBChB MD FRCS Consultant Oncoplastic.

Case 3 Jane McNicholas Consultant Oncoplastic Breast Surgeon

Breast Cancer Protocol

RCR breast radiotherapy consensus guidelines

Hypofractionated radiotherapy for breast cancer

Update of the management of

Basile Pache, Antonia Digklia*, Nicolas Demartines, Maurice Matter.

Case scenario- Breast Lump

Figure 1. Age Standardized Rate of Oropharyngeal Squamous Cell Carcinoma (OPSCC) in the UK, Data courtesy of the UK HPV Prevalence Study (1)

Role of the Community Specialist Breast Care Nurse

Case scenario- Breast Lump

But how to treat those with positive SLNB? Results and Discussion

Thanh Nhan Hospital MALE BREAST CANCER: CASE REPORT

Universidad de Antioquia.

معيارهاي ارزشيابي برنامه ثبت سرطان دانشگاهي ارسال به موقع اطلاعات (هر سه ماه)(2) گردآوري از لحاظ پيدا كردن موارد جديد سرطاني از منابع ذيل: - ثبت.

徐慧萍1 羅竹君1,2 郭耀隆1 李國鼎1 國立成功大學醫學院附設醫院外科部1 國立成功大學醫學院臨床醫學研究所2

So you have been diagnosed with breast cancer! What's next?

Treatment Overview: The Multidisciplinary Team

Surgery for Breast Cancer

Presentation transcript:

Radiotherapy Protocols Bristol protocol version 12

Dose Prescription 40Gy in 15 fractions daily for the majority of patients Other dose schedules to be used at discretion of clinician and patient after discussion include: – 45Gy in 20 fractions daily. – 50Gy in 25 fractions daily

CHEST WALL (POST MASTECTOMY) Radiotherapy to the chest wall is indicated if the: Tumour extends to the excision margin. 4 or more lymph nodes are involved on histological examination. Margin >1mm. Skin involvement. Tumour >5cm diameter. Multi-focal grade 3, T2N0 and grade 3 histology and/or lymphovascular invasion. N1 patients can also be considered If in the opinion of the Breast MDT the patient is deemed suitable for this

CHEST WALL (POST MASTECTOMY) Dose Prescription 40Gy in 15 fractions daily. 45Gy in 20 fractions daily. 50Gy in 25 fractions daily – the preferred dose for a reconstructed breast ???

SUPRACLAVICULAR FOSSA and AXILLA Radiotherapy to the supraclavicular fossa only is indicated when: 1-3 positive lymph nodes after a level II axillary clearance and a minimum of 10 lymph nodes retrieved if other poor prognostic factors (e.g. T3 and/or grade 3 tumour). 4 or more positive lymph nodes after a level II axillary clearance and a minimum of 10 lymph nodes retrieved. After neo-adjuvant chemotherapy if considered high risk

There are no absolute indications for radiotherapy to the supraclavicular fossa and axilla but it can be considered in the following situations: No axillary surgery has been carried out (with the exception of DCIS and very good prognosis invasive carcinoma ). Palpable/+ve axillary lymph node prior to neo-adjuvant chemotherapy in patients who have had axillary sampling and no pathological complete response after neo-adjuvant chemotherapy. Sentinel node biopsy or sampling of lymph nodes is positive for axillary metastases and axillary dissection is not undertaken or the patient declines axillary clearance. Extensive extra-capsular spread. A high node positive count and/or if a high proportion of retrieved nodes are involved.